2Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to particle [J].Pharmacol Rev, 2001,53 : 283-318.
3I.ee JH, Jung SW, Kim IS, et al. Polymeric nanoparlicle composed of fatty acids and poly (ethylene glycol) asadrugcarrier[J].IntJ Pharm,2003,251:23-32.
4Chan KK,Chlebowski RT,Ton M, et al Clinical pHarmacokinetics of adriamycin in hepatoma patients with cirrhosis[J].Cancer Res, 1980,40(4) :1 263.
5Maeyama I, Furuse K, Yamawaki S, et al. Evaluation of adjuvant chemotherapy of osteosarcoma with special reference to adriamyein[J].Gan To Kagaku Ryoho, 1988,15(12):3 245-3 251.
6Hofman MA, Purba JS, Swaab DF. Annual variations in the vasopressin neuron population of the human suprachias matic nucleus[J].Neuroscience, 1993,53 (4) : 1 103-1 112.
7Nobuto H,Sugita T,Kubo T,et al. Evaluation of systemic chemotherapy with magnetic liposomal doxorubicin and a dipole external electromagnet[J]. Int J Cancer, 2004,109 (4) : 627-635.
8Ivkov R, DeNardo SJ, Daum W, et al. Application of high amplitude alternating magnetic fields for heat induction of nanoparticles localized in cancer[J]. Clin Cancer Res,2005,11(19Pt2) :7 093-7 103.
9Lemke AJ,Senfft von Pilsach MI,Liibbe A, et al. MRI after magnetic drug targeting in patients with advanced solid malignant tumors [J].Eur Radiol, 2004,14 ( 11 ) : 1 949-1 955.
10Johannsen M, Gneveckow U, Eckelt L, et al. Clinical hyperthermia of prostate cancer using magnetic nanoparticles., presentation of a new interstitial technique[J].Int J Hyperthermia, 2005,21 (7) : 637-647.
